Lantheus Holdings, Inc (LNTH) is a publicly traded Healthcare sector company. As of October 22, 2026, LNTH trades at $99.53 with a market cap of $6.56B and a P/E ratio of 23.67. LNTH moved -0.71% today. Year to date, LNTH is +49.01%; over the trailing twelve months it is +73.73%. Its 52-week range spans $47.25 to $111.86. Analyst consensus is neutral with an average price target of $104.48. Rallies surfaces LNTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
FTC seeks additional information on Curium's acquisition of Lantheus: Lantheus and Curium US Holdings received FTC requests for additional information on October 21, extending review of their merger. The companies still expect the acquisition to close in the first half of 2027, subject to clearance and other closing conditions.
| Metric | Value |
|---|---|
| Price | $99.53 |
| Market Cap | $6.56B |
| P/E Ratio | 23.67 |
| EPS | $4.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $111.86 |
| 52-Week Low | $47.25 |
| Volume | 10.85K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.56B |
| Net Income | $275.31M |
| Gross Margin | 60.14% |
9 analysts cover LNTH: 0 strong buy, 0 buy, 9 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $104.48.